Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Eleuterio R. Hernandez"'
Autor:
Giuliana Baccino, Buenaventura Coroleu Lletget, Alberto Romeu, Ana Monzó, Mónica Romeu, Fernando Abellán-García Sánchez, Isidoro Bruna Catalán, Azucena Zapata, Juan A. García-Velasco, Elisabetta Ricciarelli, Sylvia Fernández-Shaw, José Luis Gómez Palomares, Javier Sánchez Caro, Jorge Cuadros Fernández, Federico Pérez Milán, Sofía Gameiro, Emilio Lizarraga Bonelli, Guido Pennings, Ricardo Loret de Mola, Susan Golombok, Marco Antonio Pessanha Lourenço, Débora Cristina Soares Faria, Ludmila Araujo Cruz, Marisa Herrera, R. Sergio Pasqualini, Eleuterio R. Hernández de Miguel
El enorme avance en el conocimiento de las bases moleculares de los procesos fisiológicos y de las bases de la enfermedad que se produce en la segunda mitad del siglo pasado da lugar a la configuración del llamado modelo biomédico o molecular del
Autor:
José Luis Simón Gómez, Belen Acevedo, Marta Gutiérrez Sánchez, Jorge Cuadros, Elisabetta Ricciarelli, Eleuterio R. Hernandez
Publikováno v:
Fertility and Sterility. 82:343-347
Objective To determine whether LH supplementation improved pregnancy and implantation rates in GnRH antagonist donor cycles. Design Donors were randomly assigned to a protocol using GnRH antagonist (GnRH-a) alone or GnRH-a + recombinant LH. Analysis
Autor:
Eleuterio R. Hernandez
Publikováno v:
Human Reproduction. 15:1211-1216
When gonadotrophin-releasing hormone (GnRH) was discovered, the agonist and antagonist of GnRH were developed to control the release of FSH and LH by the gonadotrophs. More than 10 years of research were needed to develop a GnRH antagonist free of hi
Publikováno v:
Endocrinology. 132:2703-2708
A growing body of information now supports the existence of a complete intraovarian insulin-like growth Factor I (IGF-I) system replete with ligands, receptors, and binding protein(s). However, studies concerned with the regulation of ovarian IGF-I g
Publikováno v:
Endocrinology. 131:1643-1649
An increasing body of information now suggests that intraovarian interleukin-1 (IL-1) may play an intermediary role in the ovulatory process. Given that follicular rupture inevitably requires marked tissue remodeling and possibly cell death, we set o
Autor:
M J Levy, R J Stillman, Charles T. Roberts, Eleuterio R. Hernandez, Eli Y. Adashi, Derek LeRoith
Publikováno v:
Endocrinology. 131:1202-1206
Solution hybridization/RNase protection assays were used to study the developmental expression of the insulin-like growth factor-I (IGF-I), IGF-II, IGF-I receptor, and IGF-II/mannose-6-phosphate receptor genes in the rat ovary between postnatal days
Autor:
Eleuterio R. Hernandez, Teresa Palese, C T Roberts, D LeRoith, A. Avinoam Kowarski, M Phillip
Publikováno v:
Endocrinology. 130:2865-2870
Circulating levels of insulin-like growth factor-I (IGF-I) increase during puberty, concurrent with an increase in the levels of GH and the gonadal steroids. The relationship between the changes observed in IGF-I and testosterone (T) levels are not u
Autor:
Eleuterio R. Hernandez
Publikováno v:
Human reproduction (Oxford, England). 24(7)
Many published papers suggest a favourable impact of preimplantation genetic screening (PGS) on implantation and pregnancy rates, but more recent randomized studies have not confirmed, or could not conclude, that PGS actually improved implantation ra
Autor:
Derek LeRoith, Arye Hurwitz, Elisabetta Ricciarelli, Haim Werner, Eli Y. Adashi, Charles T. Roberts, Eleuterio R. Hernandez, Luis Botero
Publikováno v:
Molecular Endocrinology. 5:1799-1805
The intraovarian insulin-like growth factor (IGF) system constitutes a triad composed of ligands, receptors, and binding proteins. Although conventional radioligand receptor assays have documented the presence of specific receptors for insulin and in
Autor:
Arye Hurwitz, Derek LeRoith, Carol E. Resnick, Elisabetta Ricciarelli, Eleuterio R. Hernandez, Ron G. Rosenfeld, Eli Y. Adashi, Charles T. Roberts
Publikováno v:
Human Reproduction. 6:1213-1219
A large body of information now supports the existence of a complete intraovarian insulin-like growth factor (IGF) system replete with ligands, receptors, and binding proteins. Although much remains to be learned, the emerging consensus would suggest